Your browser doesn't support javascript.
loading
A 96-week comparison of lopinavir-ritonavir combination therapy followed by lopinavir-ritonavir monotherapy versus efavirenz combination therapy.
Cameron, D William; da Silva, Barbara A; Arribas, Jose R; Myers, Robert A; Bellos, Nicholaos C; Gilmore, Norbert; King, Martin S; Bernstein, Barry M; Brun, Scott C; Hanna, George J.
Affiliation
  • Cameron DW; Division of Infectious Diseases, University of Ottawa at The Ottawa Hospital, Ottawa, Ontario, Canada.
J Infect Dis ; 198(2): 234-40, 2008 Jul 15.
Article in En | MEDLINE | ID: mdl-18540803
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrimidinones / Acquired Immunodeficiency Syndrome / HIV Protease Inhibitors / Ritonavir / Anti-HIV Agents / Benzoxazines Type of study: Clinical_trials Limits: Humans Language: En Journal: J Infect Dis Year: 2008 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrimidinones / Acquired Immunodeficiency Syndrome / HIV Protease Inhibitors / Ritonavir / Anti-HIV Agents / Benzoxazines Type of study: Clinical_trials Limits: Humans Language: En Journal: J Infect Dis Year: 2008 Document type: Article Affiliation country: Country of publication: